ヒアルロン酸のグローバル市場2023~2027:皮膚フィラー、変形性関節症、眼科、膀胱尿管逆流

■ 英語タイトル:Global Hyaluronic Acid Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR75120-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR75120-23
■ 発行日:2023年3月23日
■ 調査対象地域:北米、アジア太平洋、ヨーロッパ、中東・アフリカ、南米
■ 産業分野:化学
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヒアルロン酸のグローバル市場2023~2027:皮膚フィラー、変形性関節症、眼科、膀胱尿管逆流]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Technavio社の本報告書では、世界のヒアルロン酸市場規模が2022年から2027年の間に3719.76百万ドルまで上昇すると推定しており、予測期間中にCAGR 7.3%成長する見込みです。本書ではヒアルロン酸の世界市場を調査し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、用途別(皮膚フィラー、変形性関節症、眼科、膀胱尿管逆流)分析、エンドユーザー別(製薬、化粧品)分析、地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、ドイツ、中国、韓国)分析、顧客状況、推進要因・課題・動向、企業状況、企業分析などの内容をまとめました。なお、AbbVie Inc., Anika Therapeutics Inc., Bausch Health Co. Inc., Bioplus Co. Ltd., Bioxis Pharmaceutical, Bloomage Biotechnology Corp Ltd., Ferring BV, Fidia Farmaceutici Spa, Galderma SA, Huadong Medicine Co. Ltd., Laboratoires VIVACY SAS, LG Chem Ltd., Merz Pharma GmbH and Co KGaA, Sanofi SA, Seikagaku Corp., Smith and Nephew plc, SyrHA Trading SA, Teva Pharmaceutical Industries Ltd., Zimmer Biomet Holdings Inc., ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke, BioScience GmbH Cosmetics Trading LLCなどの関連企業情報が収録されています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のヒアルロン酸市場規模:用途別
- 皮膚フィラー用ヒアルロン酸の市場規模
- 変形性関節症用ヒアルロン酸の市場規模
- 眼科用ヒアルロン酸の市場規模
- 膀胱尿管逆流用ヒアルロン酸の市場規模
・世界のヒアルロン酸市場規模:エンドユーザー別
- 製薬における市場規模
- 化粧品における市場規模
・顧客状況
・世界のヒアルロン酸市場規模:地域別
- 北米のヒアルロン酸市場規模
- アジア太平洋のヒアルロン酸市場規模
- ヨーロッパのヒアルロン酸市場規模
- 南米のヒアルロン酸市場規模
- 中東・アフリカのヒアルロン酸市場規模
- アメリカのヒアルロン酸市場規模
- 中国のヒアルロン酸市場規模
- カナダのヒアルロン酸市場規模
- ドイツのヒアルロン酸市場規模
- 韓国のヒアルロン酸市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの主なパラメーターを分析することにより、複数の情報源からのデータを調査・統合・統括することで、ヒアルロン酸市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、多様な市場の側面を提示します。これらのデータは包括的​​且つ信頼性が高く、一次・二次の広範な調査の結果です。Technavio社の市場調査資料は、正確なヒアルロン酸市場の成長を予測するため、定性的・定量的調査により徹底的な競合状況、詳細に及ぶベンダー選定&分析を提供します。

ヒアルロン酸の世界市場 2023-2027

Technavio社は、ヒアルロン酸市場をモニターしており、2022年から2027年にかけて3,719.76百万ドルの成長が予測され、予測期間中のCAGRは7.3%で加速すると予測しています。この調査レポートは、ヒアルロン酸市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、最小限のモニタリングで済む安全で安定した医薬品へのニーズ、生産設備拡張への投資の増加、人々の健康意識の高まりです。

Technavioのヒアルロン酸市場は以下のようにセグメント化されています:

・用途別:
– 皮膚充填剤
– 変形性関節症
– 眼科
– 膀胱尿管逆流症

・エンドユーザー別:
– 製薬産業
– 化粧品産業

・地域別:
– 北米
– アジア太平洋
– ヨーロッパ
– 中東・アフリカ
– 南米

この研究では、今後数年間のヒアルロン酸市場の成長を促進する主な理由の一つとして、買収や合弁事業の増加を挙げています。また、技術の進歩とスキンケア製品におけるHAの応用拡大も、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメーターの分析によって、市場の詳細な姿を提示します。

ヒアルロン酸市場に関する弊社のレポートは以下の分野をカバーしています:
– ヒアルロン酸市場のサイジング
– ヒアルロン酸市場予測
– ヒアルロン酸市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AbbVie Inc., ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke, Anika Therapeutics Inc., Bausch Health Co. Inc., Bioplus Co. Ltd., BioScience GmbH Cosmetics Trading LLC, Bioxis Pharmaceutical, Bloomage Biotechnology Corp Ltd., Ferring BV, Fidia Farmaceutici Spa, Galderma SA, Huadong Medicine Co. Ltd., Laboratoires VIVACY SAS, LG Chem Ltd., Merz Pharma GmbH and Co KGaA, Sanofi SA, Seikagaku Corp., Smith and Nephew plc, SyrHA Trading SA, Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holdings Incなどの企業情報が含まれています。また、ヒアルロン酸市場分析レポートには、市場成長に影響を与える今後の動向と課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。

この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hyaluronic acid market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global hyaluronic acid market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 End-users Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-users Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Dermal fillers – Market size and forecast 2022-2027
o Exhibit 34: Chart on Dermal fillers – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Dermal fillers – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Dermal fillers – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Dermal fillers – Year-over-year growth 2022-2027 (%)
o 6.4 Osteoarthritis – Market size and forecast 2022-2027
o Exhibit 38: Chart on Osteoarthritis – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Osteoarthritis – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Osteoarthritis – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Osteoarthritis – Year-over-year growth 2022-2027 (%)
o 6.5 Ophthalmic – Market size and forecast 2022-2027
o Exhibit 42: Chart on Ophthalmic – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Ophthalmic – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Ophthalmic – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Ophthalmic – Year-over-year growth 2022-2027 (%)
o 6.6 Vesicoureteral reflux – Market size and forecast 2022-2027
o Exhibit 46: Chart on Vesicoureteral reflux – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Vesicoureteral reflux – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Vesicoureteral reflux – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Vesicoureteral reflux – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ million)
o Exhibit 51: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 53: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Pharmaceutical industry – Market size and forecast 2022-2027
o Exhibit 56: Chart on Pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o 7.4 Cosmetic industry – Market size and forecast 2022-2027
o Exhibit 60: Chart on Cosmetic industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Cosmetic industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Cosmetic industry – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Cosmetic industry – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 APAC – Market size and forecast 2022-2027
o Exhibit 75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on APAC – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Middle East and Africa – Market size and forecast 2022-2027
o Exhibit 83: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o 9.7 South America – Market size and forecast 2022-2027
o Exhibit 87: Chart on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on South America – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on South America – Year-over-year growth 2022-2027 (%)
o 9.8 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 South Korea – Market size and forecast 2022-2027
o Exhibit 103: Chart on South Korea – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on South Korea – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on South Korea – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on South Korea – Year-over-year growth 2022-2027 (%)
o 9.12 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity by geography
o Exhibit 111: Market opportunity by geography ($ million)
o Exhibit 112: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. – Overview
o Exhibit 120: AbbVie Inc. – Product / Service
o Exhibit 121: AbbVie Inc. – Key news
o Exhibit 122: AbbVie Inc. – Key offerings
o 12.4 ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke
o Exhibit 123: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Overview
o Exhibit 124: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Product / Service
o Exhibit 125: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Key news
o Exhibit 126: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Key offerings
o 12.5 Anika Therapeutics Inc.
o Exhibit 127: Anika Therapeutics Inc. – Overview
o Exhibit 128: Anika Therapeutics Inc. – Product / Service
o Exhibit 129: Anika Therapeutics Inc. – Key offerings
o 12.6 Bausch Health Co. Inc.
o Exhibit 130: Bausch Health Co. Inc. – Overview
o Exhibit 131: Bausch Health Co. Inc. – Business segments
o Exhibit 132: Bausch Health Co. Inc. – Key news
o Exhibit 133: Bausch Health Co. Inc. – Key offerings
o Exhibit 134: Bausch Health Co. Inc. – Segment focus
o 12.7 Bioxis Pharmaceutical
o Exhibit 135: Bioxis Pharmaceutical – Overview
o Exhibit 136: Bioxis Pharmaceutical – Product / Service
o Exhibit 137: Bioxis Pharmaceutical – Key offerings
o 12.8 Bloomage Biotechnology Corp Ltd.
o Exhibit 138: Bloomage Biotechnology Corp Ltd. – Overview
o Exhibit 139: Bloomage Biotechnology Corp Ltd. – Product / Service
o Exhibit 140: Bloomage Biotechnology Corp Ltd. – Key offerings
o 12.9 Ferring BV
o Exhibit 141: Ferring BV – Overview
o Exhibit 142: Ferring BV – Product / Service
o Exhibit 143: Ferring BV – Key offerings
o 12.10 Fidia Farmaceutici Spa
o Exhibit 144: Fidia Farmaceutici Spa – Overview
o Exhibit 145: Fidia Farmaceutici Spa – Product / Service
o Exhibit 146: Fidia Farmaceutici Spa – Key offerings
o 12.11 Galderma SA
o Exhibit 147: Galderma SA – Overview
o Exhibit 148: Galderma SA – Product / Service
o Exhibit 149: Galderma SA – Key news
o Exhibit 150: Galderma SA – Key offerings
o 12.12 LG Chem Ltd.
o Exhibit 151: LG Chem Ltd. – Overview
o Exhibit 152: LG Chem Ltd. – Business segments
o Exhibit 153: LG Chem Ltd. – Key news
o Exhibit 154: LG Chem Ltd. – Key offerings
o Exhibit 155: LG Chem Ltd. – Segment focus
o 12.13 Merz Pharma GmbH and Co KGaA
o Exhibit 156: Merz Pharma GmbH and Co KGaA – Overview
o Exhibit 157: Merz Pharma GmbH and Co KGaA – Product / Service
o Exhibit 158: Merz Pharma GmbH and Co KGaA – Key offerings
o 12.14 Sanofi SA
o Exhibit 159: Sanofi SA – Overview
o Exhibit 160: Sanofi SA – Business segments
o Exhibit 161: Sanofi SA – Key news
o Exhibit 162: Sanofi SA – Key offerings
o Exhibit 163: Sanofi SA – Segment focus
o 12.15 Smith and Nephew plc
o Exhibit 164: Smith and Nephew plc – Overview
o Exhibit 165: Smith and Nephew plc – Business segments
o Exhibit 166: Smith and Nephew plc – Key news
o Exhibit 167: Smith and Nephew plc – Key offerings
o Exhibit 168: Smith and Nephew plc – Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 169: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 170: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 171: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 172: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 173: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Zimmer Biomet Holdings Inc.
o Exhibit 174: Zimmer Biomet Holdings Inc. – Overview
o Exhibit 175: Zimmer Biomet Holdings Inc. – Business segments
o Exhibit 176: Zimmer Biomet Holdings Inc. – Key news
o Exhibit 177: Zimmer Biomet Holdings Inc. – Key offerings
o Exhibit 178: Zimmer Biomet Holdings Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global hyaluronic acid market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-users Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Dermal fillers – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Dermal fillers – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Dermal fillers – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Dermal fillers – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Osteoarthritis – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Osteoarthritis – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Osteoarthritis – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Osteoarthritis – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Ophthalmic – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Ophthalmic – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Ophthalmic – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Ophthalmic – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Vesicoureteral reflux – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Vesicoureteral reflux – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Vesicoureteral reflux – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Vesicoureteral reflux – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on End-user – Market share 2022-2027 (%)
Exhibits53: Data Table on End-user – Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Cosmetic industry – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Cosmetic industry – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Cosmetic industry – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Cosmetic industry – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on APAC – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on South America – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on South America – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on South America – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on South America – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on South Korea – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on South Korea – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on South Korea – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on South Korea – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity by geography ($ million)
Exhibits112: Data Tables on Market opportunity by geography ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. – Overview
Exhibits120: AbbVie Inc. – Product / Service
Exhibits121: AbbVie Inc. – Key news
Exhibits122: AbbVie Inc. – Key offerings
Exhibits123: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Overview
Exhibits124: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Product / Service
Exhibits125: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Key news
Exhibits126: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke – Key offerings
Exhibits127: Anika Therapeutics Inc. – Overview
Exhibits128: Anika Therapeutics Inc. – Product / Service
Exhibits129: Anika Therapeutics Inc. – Key offerings
Exhibits130: Bausch Health Co. Inc. – Overview
Exhibits131: Bausch Health Co. Inc. – Business segments
Exhibits132: Bausch Health Co. Inc. – Key news
Exhibits133: Bausch Health Co. Inc. – Key offerings
Exhibits134: Bausch Health Co. Inc. – Segment focus
Exhibits135: Bioxis Pharmaceutical – Overview
Exhibits136: Bioxis Pharmaceutical – Product / Service
Exhibits137: Bioxis Pharmaceutical – Key offerings
Exhibits138: Bloomage Biotechnology Corp Ltd. – Overview
Exhibits139: Bloomage Biotechnology Corp Ltd. – Product / Service
Exhibits140: Bloomage Biotechnology Corp Ltd. – Key offerings
Exhibits141: Ferring BV – Overview
Exhibits142: Ferring BV – Product / Service
Exhibits143: Ferring BV – Key offerings
Exhibits144: Fidia Farmaceutici Spa – Overview
Exhibits145: Fidia Farmaceutici Spa – Product / Service
Exhibits146: Fidia Farmaceutici Spa – Key offerings
Exhibits147: Galderma SA – Overview
Exhibits148: Galderma SA – Product / Service
Exhibits149: Galderma SA – Key news
Exhibits150: Galderma SA – Key offerings
Exhibits151: LG Chem Ltd. – Overview
Exhibits152: LG Chem Ltd. – Business segments
Exhibits153: LG Chem Ltd. – Key news
Exhibits154: LG Chem Ltd. – Key offerings
Exhibits155: LG Chem Ltd. – Segment focus
Exhibits156: Merz Pharma GmbH and Co KGaA – Overview
Exhibits157: Merz Pharma GmbH and Co KGaA – Product / Service
Exhibits158: Merz Pharma GmbH and Co KGaA – Key offerings
Exhibits159: Sanofi SA – Overview
Exhibits160: Sanofi SA – Business segments
Exhibits161: Sanofi SA – Key news
Exhibits162: Sanofi SA – Key offerings
Exhibits163: Sanofi SA – Segment focus
Exhibits164: Smith and Nephew plc – Overview
Exhibits165: Smith and Nephew plc – Business segments
Exhibits166: Smith and Nephew plc – Key news
Exhibits167: Smith and Nephew plc – Key offerings
Exhibits168: Smith and Nephew plc – Segment focus
Exhibits169: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits170: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits171: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits172: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits174: Zimmer Biomet Holdings Inc. – Overview
Exhibits175: Zimmer Biomet Holdings Inc. – Business segments
Exhibits176: Zimmer Biomet Holdings Inc. – Key news
Exhibits177: Zimmer Biomet Holdings Inc. – Key offerings
Exhibits178: Zimmer Biomet Holdings Inc. – Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR75120-23 )"ヒアルロン酸のグローバル市場2023~2027:皮膚フィラー、変形性関節症、眼科、膀胱尿管逆流" (英文:Global Hyaluronic Acid Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。